14 research outputs found

    Reactions of Nā€‘Heterocyclic Carbene Boranes with 5ā€‘Diazo-2,2-dimethyl-1,3-dioxane-4,6-dione: Synthesis of Mono- and Bis-hydrazonyl NHC-Boranes

    No full text
    N-Heterocyclic carbene boranes (NHC-boranes) react with 5-diazo-2,2-dimethyl-1,3-dioxane-4,6-dione at 40 Ā°C in dichloromethane to provide NHC-boryl hydrazone derivatives of 2,2-dimethyl-1,3-dioxane-4,6-dione. These hydrazones disproportionate to bis-hydrazones on treatment with diiodine in dichloromethane at room temperature. The mono- and bis-hydrazones are yellow solids that are stable to chromatography and storage

    Reactions of Nā€‘Heterocyclic Carbene Boranes with 5ā€‘Diazo-2,2-dimethyl-1,3-dioxane-4,6-dione: Synthesis of Mono- and Bis-hydrazonyl NHC-Boranes

    No full text
    N-Heterocyclic carbene boranes (NHC-boranes) react with 5-diazo-2,2-dimethyl-1,3-dioxane-4,6-dione at 40 Ā°C in dichloromethane to provide NHC-boryl hydrazone derivatives of 2,2-dimethyl-1,3-dioxane-4,6-dione. These hydrazones disproportionate to bis-hydrazones on treatment with diiodine in dichloromethane at room temperature. The mono- and bis-hydrazones are yellow solids that are stable to chromatography and storage

    High Catalytic Activity in the Phenol Hydroxylation of Magnetically Separable CuFe<sub>2</sub>O<sub>4</sub>ā€“Reduced Graphene Oxide

    No full text
    We reported a highly active CuFe<sub>2</sub>O<sub>4</sub> catalyst modified with reduced graphene oxide (CuFe<sub>2</sub>O<sub>4</sub>ā€“RGO) by a solvothermal method. The composite catalyst was fully characterized by FTIR, XRD, Raman, TEM, and XPS, which demonstrated that the CuFe<sub>2</sub>O<sub>4</sub> nanoparticles (NPs) with a diameter of approximately 17.8 nm were densely and compactly deposited on the reduced graphene oxide (RGO) sheets. The as-prepared CuFe<sub>2</sub>O<sub>4</sub>ā€“RGO composites were used to catalyze phenol hydroxylation for the first time, which exhibited great catalytic activity. The conversion rate of phenol to dihydroxybenzenes reached 35.5% with a selectivity of 95.2% obtained, which is much higher than for reported systems (25.0%). The catalytic activity remained high after six cycles. More importantly, the catalyst can be easily recovered due to its magnetic separability and the organic solvent-free nature of the phenol hydroxylation process. A possible mechanism in phenol hydroxylation by H<sub>2</sub>O<sub>2</sub> over CuFe<sub>2</sub>O<sub>4</sub>ā€“RGO<sub>20</sub> catalyst was also proposed

    Highly Chemoselective and Enantioselective Catalytic Oxidation of Heteroaromatic Sulfides via High-Valent Manganese(IV)ā€“Oxo Cation Radical Oxidizing Intermediates

    No full text
    A manganese complex with a porphyrin-like ligand that catalyzes the highly chemoselective and enantioselective oxidation of heteroaromatic sulfides, including imidazole, benzimidazole, indole, pyridine, pyrimidine, pyrazine, <i>sym</i>-triazine, thiophene, thiazole, benzothiazole, and benzoxazole, with hydrogen peroxide is described, furnishing the corresponding sulfoxides in good to excellent yields and enantioselectivities (up to 90% yield and up to >99% ee) within a short reaction time (0.5 h). The practical utility of the method has been demonstrated in the gram-scale synthesis of chiral sulfoxide. Mechanistic studies, performed with <sup>18</sup>O-labeled water (H<sub>2</sub><sup>18</sup>O), hydrogen peroxide (H<sub>2</sub><sup>18</sup>O<sub>2</sub>), and cumyl hydroperoxide, reveal that a high-valent manganeseā€“oxo species is generated as the oxygen atom delivering agent via carboxylic acid assisted heterolysis of Oā€“O bonds. Density functional theory (DFT) calculations were also carried out to give further insight into the mechanism of manganese-catalyzed sulfoxidation. On the basis of the theoretical study, the coupled high-valent manganeseĀ­(IV)ā€“oxo cation radical species, which bears obvious similarities with that of reactive intermediates in the catalytic oxygenation reactions based on the cytochrome P450 and metalloporphyrin models, has been proposed as the reactive oxidant in the non-heme manganese catalyst system

    Asymmetric Epoxidation of Alkenes Catalyzed by a Porphyrin-Inspired Manganese Complex

    No full text
    A novel strategy for catalytic asymmetric epoxidation of a wide variety of olefins by a porphyrin-inspired chiral manganese complex using H<sub>2</sub>O<sub>2</sub> as a terminal oxidant in excellent yield with up to greater than 99% ee has been successfully developed

    Exhaustive Hydrodefluorination or Deuterodefluorination of Trifluoromethylarenes via Metal-Free Photoredox Catalysis

    No full text
    Perfluoroalkyl compounds are persistent environmental pollutants due to their chemical and thermal stability. Hydrodefluorination is one of the most promising strategies for the disposal of fluorine-containing compounds, which has attracted much attention from a broad spectrum of scientific communities. Herein, we disclose a metal-free, visible-light-promoted protocol for the exhaustive hydrodefluorination of a wide variety of trifluoromethylarenes with up to 95% yields. Moreover, methyl-d3 groups can be obtained via deuterium water with a D ratio of up to 94%

    Hepatic apoA5 and PPARĪ± mRNA and protein expressions in rats.

    No full text
    <p>The mRNA and protein levels of hepatic apoA5 and PPARĪ± in rats were detected by RT-qPCR and Western blot analysis respectively: (A and B) ApoA5 mRNA and protein- Compared with control group, a significant reduction of apoA5 mRNA and protein was observed in fructose group. However, the two treatments effectively ameliorated fructose-induced down-regulation of apoA5 expressions, whereas this effect was more considerable in XZK group. (C and D) PPARĪ± mRNA and protein- Similar findings of hepatic PPARĪ± expressions were obtained, i.e. the two treatments attenuated fructose-induced down-regulation of hepatic PPARĪ± expressions but this effect was more remarkable in XZK group. E ApoA5 and PPARĪ± protein results by Western blot analysis. *<sup>, #, &</sup> Values were significantly different from control, fructose, and statin groups, respectively (P < 0.05). ApoA5, apolipoprotein A5; PPARĪ±, peroxisome proliferator-activated receptor Ī±; XZK, Xuezhikang.</p

    LDL-R, TG, apoA5 and PPARĪ± in HepG2 cells.

    No full text
    <p>(A-B) LDL-R protein expressions: Two protein bands of LDL-R were exhibited including its precursor (120 kDa) and mature (160 kDa) forms. No significant difference of LDL-R expressions was indicated between the two treatments. (C) TG contents: The two agents effectively ameliorated fructose-induced TG elevation but this effect was more considerable in XZK group. Interestingly, PPARĪ± down-regulation by shRNA effectively inhibited XZK-induced hypotriglyceridemic actions. (D-H) mRNA and protein of ApoA5 and PPARĪ±: The two agents remarkably ameliorated fructose-induced down-regulation of apoA5 and PPARĪ± mRNA and protein, whereas these effects were more significant in XZK group than statin group. However, PPARĪ± knockdown eliminated these above effects of XZK. *<sup>, #, &, Ā§</sup> Values were significantly different from control, fructose, statin and XZK group, respectively (P < 0.05). LDL-R, low density lipoprotein receptor; TG, triglyceride; ApoA5, apolipoprotein A5; PPARĪ±, peroxisome proliferator-activated receptor Ī±; XZK, Xuezhikang.</p

    Asymmetric Epoxidation of Olefins with Hydrogen Peroxide by an in Situ-Formed Manganese Complex

    No full text
    Asymmetric epoxidation of a variety of cis, trans, terminal, and trisubstituted olefins in excellent yields (up to 94%) and enantioselectivities (>99% ee) by an in situ-formed manganese complex using H<sub>2</sub>O<sub>2</sub> has been developed. A relationship between the hydrophobicity of the catalyst imposed by ligand and the catalytic activity has been observed. The influence of the amount and identity of the acid additive was examined, and improved enantioselectivities were achieved through the use of a catalytic amount of a carboxylic acid additive

    Oligonucleotide sequences of primers and shRNA targeting human PPARĪ± gene.

    No full text
    <p>Oligonucleotide sequences of primers and shRNA targeting human PPARĪ± gene.</p
    corecore